Article
Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
European journal of epidemiology - 1 Mar 2011
Parker Lucy A, Porta Miquel, Lumbreras Blanca, López Tomàs, Guarner Luisa, Hernández-Aguado Ildefonso, Carrato Alfredo, Corominas Josep M, Rifà Juli, Fernandez Esteve, Alguacil Joan, Malats Núria, Real Francisco X
Abstract excerpt
The diagnostic utility of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer (EPC) has not been properly studied, and few reports have analysed a clinically relevant spectrum of patients. The objective was to evaluate the clinical validity of detecting K-ras mutations in the diagnosis of EPC in a large sample of clinically relevant patients. We prospectively identified 374 patients in whom...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.